Delivery Order SPE2DB20D9332-SPE2DB23FV3B8

Award Date 4/17/23
Potential Completion Date 5/8/23
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,209.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the provision of the Kyleena intrauterine contraceptive system. This order was placed against DMS Pharmaceutical Group's indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $11,404.60, is for the delivery of the medical device KYLEENA 19.5 MG SYSTEMS. This contract is a task order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. The IDC allows the DLA to issue...
This is a $1,805.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Kyleena 19.5 mg intrauterine contraceptive systems and has an ultimate completion date of April 12, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, enabling the agency to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,859.07 contract is for the delivery of Kyleena 19.5 mg intrauterine systems, a contraceptive device, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of February 25, 2025. DMS Pharmaceutical Group Inc. holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,859.20 contract is for the delivery of Kyleena 19.5 MG Systems, a contraceptive device, with a period of performance through September 6, 2023. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,343.68 firm fixed-price contract is for the delivery of 4560094626 - KYLEENA 19.5 MG SYSTEMS, a type of intrauterine contraceptive device. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $2,873.50 and covers the delivery of 4565361226 KYLEENA 19.5 MG SYSTEMS. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,718.30 contract is for the supply of the contraceptive device Kyleena 19.5 mg systems. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,195.76, is for the delivery of the Kyleena 19.5 mg intrauterine system, a long-acting reversible contraceptive. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,838.70 firm fixed-price contract is to provide the DLA with 4564738490 KYLEENA 19.5 MG SYSTEMS, a medical product. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
  • SPE2DB20D9332
    Indefinite Delivery Contract
  • SPE2DB20D9332-SPE2DB23FV3B8
    Delivery Order

This is a firm fixed-price delivery order worth $5,859.20 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4560664353, which is the Kyleena 19.5 mg intrauterine system. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place orders for a wide range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to compete for a variety of federal pharmaceutical contracts. This delivery order has an ultimate completion date of May 8, 2023.

Generated 2/27/25, 12:19 PM